1.A Case of Tracheal Carcinoma Diagnosed by Rigid Bronchoscopy in Lidocaine Anaphylaxis Patient.
Byeong Kab YOON ; Hee Jung BAN ; Yong Soo KWON ; In Jae OH ; Kyu Sik KIM ; Yu Il KIM ; Sung Chul LIM ; Young Chul KIM ; Sang Yoon SONG
Tuberculosis and Respiratory Diseases 2009;67(2):140-144
		                        		
		                        			
		                        			The majority of flexible bronchoscopies are performed under topical anesthesia with lidocaine being the most commonly used agent. Anaphylaxis rarely occurs after local administration of lidocaine, but can be a fatal complication. We experienced a case of unexpected anaphylaxis. A 66-year-old woman was scheduled for flexible bronchoscopy to evaluate a tracheal mass and stenosis. The oral and nasal mucosa were pretreated with lidocaine. About 2~3 minutes later, the patient developed hypotension and we treated for anaphylaxis in the emergency room. Then, we decided to perform rigid bronchoscopy in this patient, under conditions of general anesthesia. A rigid bronchoscopy was performed in this patient, safely and successfully. The tracheal mass was determined to be squamous cell carcinoma.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Anaphylaxis
		                        			;
		                        		
		                        			Anesthesia
		                        			;
		                        		
		                        			Anesthesia, General
		                        			;
		                        		
		                        			Bronchoscopy
		                        			;
		                        		
		                        			Carcinoma, Squamous Cell
		                        			;
		                        		
		                        			Constriction, Pathologic
		                        			;
		                        		
		                        			Emergencies
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypotension
		                        			;
		                        		
		                        			Lidocaine
		                        			;
		                        		
		                        			Nasal Mucosa
		                        			
		                        		
		                        	
2.A Case of Anisakiasis Concurrently Invading Esophagus and Stomach, and Another Case of Esophageal Anisakiasis.
Jong Hyun KIM ; Jung Up HWANG ; Sang Hyun KIM ; Kyu Hak KIM ; Seong Joo KANG ; Kab Sik KIM ; Jong Hyun HUR ; Seong Ho CHOI
Korean Journal of Gastrointestinal Endoscopy 2006;32(2):116-119
		                        		
		                        			
		                        			Human anisakiasis may occur after ingestion of raw marine fish infected with the nematode larvae of Anisakidae. Clinical symptoms such as cramping abdominal pain, nausea, vomiting, diarrhea and epigastric fullness, usually develop within 12 hours after having eaten infected raw sea fish. Anisakiasis is most commonly found in the stomach, and is rarely identified in the small intestine, large intestine, and esophagus. We report two cases of of anisakiasis, one with concurrent invasion of the stomach and esophagus, and the other case with esophageal anisakiasis. Both were treated by endoscopic extraction of the larvae.
		                        		
		                        		
		                        		
		                        			Abdominal Pain
		                        			;
		                        		
		                        			Anisakiasis*
		                        			;
		                        		
		                        			Anisakis
		                        			;
		                        		
		                        			Diarrhea
		                        			;
		                        		
		                        			Eating
		                        			;
		                        		
		                        			Esophagus*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Intestine, Large
		                        			;
		                        		
		                        			Intestine, Small
		                        			;
		                        		
		                        			Larva
		                        			;
		                        		
		                        			Muscle Cramp
		                        			;
		                        		
		                        			Nausea
		                        			;
		                        		
		                        			Stomach*
		                        			;
		                        		
		                        			Vomiting
		                        			
		                        		
		                        	
3.Randomized, Multi-center Phase II Trial of Docetaxel Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-Small Cell Lung Cancer.
Nam Su LEE ; Hee Sook PARK ; Jong Ho WON ; Dae Sik HONG ; Su Taek UH ; Sang Jae LEE ; Joo Hang KIM ; Se Kyu KIM ; Myung Ju AHN ; Jung Hye CHOI ; Suk Chul YANG ; Jung Ae LEE ; Keun Seok LEE ; Chang Yeol YIM ; Yong Chul LEE ; Chul Soo KIM ; Moon Hee LEE ; Kab Do JUNG ; Hanlim MOON ; Yl Sub LEE
Cancer Research and Treatment 2005;37(6):332-338
		                        		
		                        			
		                        			PURPOSE: We prospectively conducted a multi-center, open-label, randomized phase II trial to compare the efficacy and safety of docetaxel plus cisplatin (DC) and etoposide plus cisplatin (EC) for treating advanced stage non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: Seventy-eight previously untreated patients with locally advanced, recurrent or metastatic NSCLC were enrolled in this study. The patients received cisplatin 75 mg/m2 on day 1 and either docetaxel 75 mg/m2 on day 1 or etoposide 100 mg/m2 on days 1 to 3 in the DC or EC arm, respectively, every 3 weeks. RESULTS: The objective response rate was 39.4% (15/38) and 18.4% (7/38) (p=0.023) in the DC and EC arms, respectively. The median time to progression (TTP) was 5.9 and 2.7 months (p=0.119), and the overall survival was 12.1 and 8.7 months (p=0.168) in the DC and EC arms, respectively. The prognostic factors for longer survival were an earlier disease stage (stage III, p=0.0095), the responders to DC (p=0.0174) and the adenocarcinoma histology (p=0.0454). The grades 3 and 4 toxicities were similar in both arms, with more febrile neutropenia (7.9% vs. 0%) and fatigue (7.9% vs. 0%) being noted in the DC arm. CONCLUSION: DC offered a superior overall response rate than does EC, along with tolerable toxicity profiles, although the DC drug combination did not show significantly improved survival and TTP.
		                        		
		                        		
		                        		
		                        			Adenocarcinoma
		                        			;
		                        		
		                        			Arm
		                        			;
		                        		
		                        			Carcinoma, Non-Small-Cell Lung*
		                        			;
		                        		
		                        			Cisplatin*
		                        			;
		                        		
		                        			Etoposide*
		                        			;
		                        		
		                        			Fatigue
		                        			;
		                        		
		                        			Febrile Neutropenia
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Prospective Studies
		                        			
		                        		
		                        	
4.Drinking Problems of Hepatitis B Virus Healthy Carriers in Korean Population.
Kab Sung KIM ; Sang Hoon PARK ; Dong Su CHO ; Jae Chang HONG ; Jong Sung KIM ; Byoung Kang PARK ; Sung Soo KIM
Journal of the Korean Academy of Family Medicine 2005;26(3):145-151
		                        		
		                        			
		                        			BACKGROUND: Heavy drinking may be a cause of serious health problems in hepatitis B virus carriers. The aim of this study was to reveal the degree of drinking problems in the Korean hepatitis B virus healthy carriers. METHODS: The subjects were 218 hepatitis B virus healthy carriers (124 males and 94 females) recruited from those who visited the Health Promotion Center of Chungnam National University Hospital for a general health check-up. Drinking problems of the subjects were evaluated by the AUDIT (Alcohol Use Disorders Identification Test) questionnaire. RESULTS: The AUDIT scores (mean+/-SD) of the male subjects (9.6+/-7.9) were significantly (P <0.001) higher than those of the female subjects (2.7+/-5.2). The individuals with heavy drinking (more than 14 drinks in males and 7 drinks in females per week) are 24 (19.4%) in males and 5 (5.3%) in females. Alcohol use disorders were suspected in 36 (29.0%) males and 4 (4.3%) females. CONCLUSION: It is suggested that, in Korea, clinical attention in primary health care should be focused on reducing the alcohol consumption among the hepatitis B virus carriers, considering a large proportion have drinking problems and the possible harmful effect on their health by heavy drinking.
		                        		
		                        		
		                        		
		                        			Alcohol Drinking
		                        			;
		                        		
		                        			Chungcheongnam-do
		                        			;
		                        		
		                        			Drinking*
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Health Promotion
		                        			;
		                        		
		                        			Hepatitis B virus*
		                        			;
		                        		
		                        			Hepatitis B*
		                        			;
		                        		
		                        			Hepatitis*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Primary Health Care
		                        			;
		                        		
		                        			Surveys and Questionnaires
		                        			
		                        		
		                        	
5.A Case of Nodular Fasciitis Misdiagnosed as Baker's Cyst in a Patient with Rheumatoid Arthritis.
Jong Hyub LEE ; Sang Hyun KIM ; Jong Hyun KIM ; Jung Up HWANG ; Kyu Hak KIM ; Seong Ju KANG ; Jong Hyun HUR ; Kab Sik KIM ; Chae Kyu KIM
The Journal of the Korean Rheumatism Association 2005;12(4):347-350
		                        		
		                        			
		                        			Nodular fasciitis is rare and benign fibroblastic proliferative disease which tends to be confused microscopically with spindle cell sarcoma. It is a distinctive lesion and a very important one because of its ability to simulate a malignant process. Histopathologically, nodular fasciitis can be grouped into three subtypes based on their relation with the fascia: subcutaneous, fascial, intramuscular. We report a case of nodular fasciitis misdiagnosed as Baker's cyst in a patient with rheumatoid arthritis.
		                        		
		                        		
		                        		
		                        			Arthritis, Rheumatoid*
		                        			;
		                        		
		                        			Fascia
		                        			;
		                        		
		                        			Fasciitis*
		                        			;
		                        		
		                        			Fibroblasts
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Popliteal Cyst*
		                        			;
		                        		
		                        			Sarcoma
		                        			
		                        		
		                        	
6.The Usefulness of Oral Rifampin as Switch Therapy for the Soft Tissue and Bone Infections Caused by Methicillin-Resistant Staphylococcus aureus.
Jong Won SOHN ; Shin Woo KIM ; Sang Woo HA ; Eung Kab LEE ; Duk Won JUNG ; Hyun Ha CHANG ; Jong Myung LEE ; Nung Soo KIM
Infection and Chemotherapy 2005;37(6):337-344
		                        		
		                        			
		                        			BACKGROUND: Rifampin is sometimes used in combination with other anti-staphylococcal agents to treat methicillin-resistant Staphylococcus aureus (MRSA) infections but few reports are available about the usefulness of rifampin against MRSA infections, especially in soft tissue and bone infections. Thus, we evaluated the efficacy of rifampin as switch therapy for soft tissue and bone infections caused by MRSA and assessed the risk factors for treatment failure. MATERIALS AND METHODS: We retrospectively studied 44 patients who had soft tissue and bone infections caused by MRSA and were treated with rifampin in combination or as monotherapy as switch therapy from January 2001 to September 2004. RESULTS: The mean age of the subjects was 50.2 years and the number of male and female were 34 and 10, respectively. Median duration of rifampin use was 32 days and 25% of the patients had artificial prostheses. Thirty one patients (79.5%, 31/39) were cured with parenteral glycopeptide followed by rifampin in combination or as monotherapy. Eight patients (8/39) recurred after the completion of treatment. The presence of hip prosthesis was the only significant risk factor (P= 0.027) in multivariate logistic regression test. Rifampin was tolerable in all cases. CONCLUSION: Rifampin as switch therapy for soft tissue and bone infection caused by MRSA was effective in 79.5% (31/39) of sujects. The treatment failure seems to be associated with unremovable infected prosthesis.
		                        		
		                        		
		                        		
		                        			Female
		                        			;
		                        		
		                        			Hip Prosthesis
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Logistic Models
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Methicillin Resistance*
		                        			;
		                        		
		                        			Methicillin-Resistant Staphylococcus aureus*
		                        			;
		                        		
		                        			Prostheses and Implants
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Rifampin*
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Treatment Failure
		                        			
		                        		
		                        	
7.The Usefulness of Oral Rifampin as Switch Therapy for the Soft Tissue and Bone Infections Caused by Methicillin-Resistant Staphylococcus aureus.
Jong Won SOHN ; Shin Woo KIM ; Sang Woo HA ; Eung Kab LEE ; Duk Won JUNG ; Hyun Ha CHANG ; Jong Myung LEE ; Nung Soo KIM
Infection and Chemotherapy 2005;37(6):337-344
		                        		
		                        			
		                        			BACKGROUND: Rifampin is sometimes used in combination with other anti-staphylococcal agents to treat methicillin-resistant Staphylococcus aureus (MRSA) infections but few reports are available about the usefulness of rifampin against MRSA infections, especially in soft tissue and bone infections. Thus, we evaluated the efficacy of rifampin as switch therapy for soft tissue and bone infections caused by MRSA and assessed the risk factors for treatment failure. MATERIALS AND METHODS: We retrospectively studied 44 patients who had soft tissue and bone infections caused by MRSA and were treated with rifampin in combination or as monotherapy as switch therapy from January 2001 to September 2004. RESULTS: The mean age of the subjects was 50.2 years and the number of male and female were 34 and 10, respectively. Median duration of rifampin use was 32 days and 25% of the patients had artificial prostheses. Thirty one patients (79.5%, 31/39) were cured with parenteral glycopeptide followed by rifampin in combination or as monotherapy. Eight patients (8/39) recurred after the completion of treatment. The presence of hip prosthesis was the only significant risk factor (P= 0.027) in multivariate logistic regression test. Rifampin was tolerable in all cases. CONCLUSION: Rifampin as switch therapy for soft tissue and bone infection caused by MRSA was effective in 79.5% (31/39) of sujects. The treatment failure seems to be associated with unremovable infected prosthesis.
		                        		
		                        		
		                        		
		                        			Female
		                        			;
		                        		
		                        			Hip Prosthesis
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Logistic Models
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Methicillin Resistance*
		                        			;
		                        		
		                        			Methicillin-Resistant Staphylococcus aureus*
		                        			;
		                        		
		                        			Prostheses and Implants
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Rifampin*
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Treatment Failure
		                        			
		                        		
		                        	
8.The Clinical Comparison of Ganglions in Hand and Foot.
Kab Seung CHOI ; Cheol Ho KWAK ; Sang Eun KIM ; Su In ROH ; Ik Su CHOI
Journal of Korean Foot and Ankle Society 2004;8(2):195-198
		                        		
		                        			
		                        			PURPOSE: To compare clinical characteristics of ganglions in hand & Foot. MATERIALS AND METHODS: Seventeen cases of ganglions located in foot and fifty-five cases in hand. Excised from Mar.1988 to Apr.2003, were included in the study. The clinical characteristics and recurrence ratio were evaluated RESULTS: The mean size of 2.2 cm in hand and 2.5 cm in foot. The most common area of ganglions are dorsum of foot and wrist. The cosmetic problem of palpable mass is the primary chief complaint of ganglions on hand and the pain is that of foot. The recurrence was found in 5 cases in hand and 4 cases in foot. The recurrence was related to incomplete excision of ganglion in foot and the large size of ganglion and incomplete excision of ganglion in hand. CONCLUSION: recurrence ratio in the cases of foot is higher than that of hand. The ganglions in foot and hand need to treated by meticulous surgical excision to prevent the recurrence.
		                        		
		                        		
		                        		
		                        			Foot*
		                        			;
		                        		
		                        			Ganglion Cysts*
		                        			;
		                        		
		                        			Hand*
		                        			;
		                        		
		                        			Recurrence
		                        			;
		                        		
		                        			Wrist
		                        			
		                        		
		                        	
9.Imaging Features of Rhabdoid Tumor of the Kidney in Children.
Sang Ho LEE ; Tae Il HAN ; Myeong Joon KIM ; Hye Kyung YOUN ; Jong Cheol KIM ; Jin Young CHUNG ; Hyun Young HAN ; Youn Seon CHOI ; Mun Kab SONG ; Kyunchul CHOEH
Journal of the Korean Radiological Society 1999;41(4):813-817
		                        		
		                        			
		                        			PURPOSE: To evaluate the difference in radiologic features of rhabdoid tumor of the kidney (RTK) in children according to the location of the tumor within the kidney. MATERIALS AND METHODS: We retrospectively reviewed the radiologic findings of pathologically confirmed RTK in seven children (5 boys and 2 girls; age range, 6 months to 4 years 8 months; median, 18 months). All subjects underwent abdominal CT. We analyzed tumor location, size, and margin; renal hilar involvement, subcapsular hematoma, calcification, necrosis, and lymphadenopathy. RTK was classified according to the location of the tumor within the kidney: A tumor that mainly located in the central portion of the kidney with or without peripheral extension was described as type I, while one located at the periphery was type II. Imaging findings between the two types were compared. RESULTS: Tumor size varied from 3 cm to 12 cm. Tumor outlines were ill-defined in four cases but relatively well-defined in three. Four tumors (57 %) were type I. Hilar involvement was found in all four and a small subcapsular hematoma in one. Three tumors (43%) were type II, and in all three, large crescent-shaped subcapsular hematomas were found. CONCLUSION: Centrally located RTK showed hilar involvement with a small subcapsular hematoma, while in cases of peripherally located RTK, a large subcapsular hematoma was present. These findings may be helpful for the differential diagnosis of other pediatric renal tumors.
		                        		
		                        		
		                        		
		                        			Child*
		                        			;
		                        		
		                        			Diagnosis, Differential
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Hematoma
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Kidney*
		                        			;
		                        		
		                        			Lymphatic Diseases
		                        			;
		                        		
		                        			Necrosis
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Rhabdoid Tumor*
		                        			;
		                        		
		                        			Tomography, X-Ray Computed
		                        			
		                        		
		                        	
10.Imaging Features of Rhabdoid Tumor of the Kidney in Children.
Sang Ho LEE ; Tae Il HAN ; Myeong Joon KIM ; Hye Kyung YOUN ; Jong Cheol KIM ; Jin Young CHUNG ; Hyun Young HAN ; Youn Seon CHOI ; Mun Kab SONG ; Kyunchul CHOEH
Journal of the Korean Radiological Society 1999;41(4):813-817
		                        		
		                        			
		                        			PURPOSE: To evaluate the difference in radiologic features of rhabdoid tumor of the kidney (RTK) in children according to the location of the tumor within the kidney. MATERIALS AND METHODS: We retrospectively reviewed the radiologic findings of pathologically confirmed RTK in seven children (5 boys and 2 girls; age range, 6 months to 4 years 8 months; median, 18 months). All subjects underwent abdominal CT. We analyzed tumor location, size, and margin; renal hilar involvement, subcapsular hematoma, calcification, necrosis, and lymphadenopathy. RTK was classified according to the location of the tumor within the kidney: A tumor that mainly located in the central portion of the kidney with or without peripheral extension was described as type I, while one located at the periphery was type II. Imaging findings between the two types were compared. RESULTS: Tumor size varied from 3 cm to 12 cm. Tumor outlines were ill-defined in four cases but relatively well-defined in three. Four tumors (57 %) were type I. Hilar involvement was found in all four and a small subcapsular hematoma in one. Three tumors (43%) were type II, and in all three, large crescent-shaped subcapsular hematomas were found. CONCLUSION: Centrally located RTK showed hilar involvement with a small subcapsular hematoma, while in cases of peripherally located RTK, a large subcapsular hematoma was present. These findings may be helpful for the differential diagnosis of other pediatric renal tumors.
		                        		
		                        		
		                        		
		                        			Child*
		                        			;
		                        		
		                        			Diagnosis, Differential
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Hematoma
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Kidney*
		                        			;
		                        		
		                        			Lymphatic Diseases
		                        			;
		                        		
		                        			Necrosis
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Rhabdoid Tumor*
		                        			;
		                        		
		                        			Tomography, X-Ray Computed
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail